US2802003A - Derivatives of 3-azabicycloheptane - Google Patents

Derivatives of 3-azabicycloheptane Download PDF

Info

Publication number
US2802003A
US2802003A US539652A US53965255A US2802003A US 2802003 A US2802003 A US 2802003A US 539652 A US539652 A US 539652A US 53965255 A US53965255 A US 53965255A US 2802003 A US2802003 A US 2802003A
Authority
US
United States
Prior art keywords
azabicycloheptane
formula
compounds
found
ether
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US539652A
Inventor
Charles H Grogan
Leonard M Rice
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GESCHICKTER FUND FOR MEDICAL RESEARCH Inc
GESCHICKTER FUND MED RES
Original Assignee
GESCHICKTER FUND MED RES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GESCHICKTER FUND MED RES filed Critical GESCHICKTER FUND MED RES
Priority to US539652A priority Critical patent/US2802003A/en
Application granted granted Critical
Publication of US2802003A publication Critical patent/US2802003A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Definitions

  • This invention relates to organic chemo-therapeutic agents and methods of their preparation, and more particularly relates to compounds of value in the treatment of cardio-vascular and other diseases. More specifically the invention relates to azabicycloheptane (3:2:0) bases, and the simple and monoand bis-quaternary salts thereof.
  • the novel compounds discovered are obtained by forming the N-dialkylaminoalkyl imides from the anhydride of cis-l,2-cyclobutane dicarboxylic acid, the reduction of these imides by suitable means to obtain N- dialkylaminoalkyl-3-azabicycloheptane bases which may be converted by appropriate means into the simple, monoand bis-quaternary salts.
  • Formula 1 shows the general structural formula of compounds obtained by the methods hereafter more par.- ticularly described. This formula depicts the free bases, and for convenience in representation the azabicycloheptane nucleus (enclosed in parenthesis, Formula 1) will be designated by the letter A hereafter.
  • Formula 2 (0Hz) H 1 i wnsrif X ⁇ R X- X ⁇ R Formula 3(a) Formula 3(1))
  • A represents the azabicycloheptane nucleus and n a number from I to 6.
  • R represents two alkyl groups with from 1 to 6 carbon atoms.
  • X- represents an anion namely, chloride, iodide, bromide, acetate or sulfate.
  • the site of both simple and quaternary salt formation on the nucleus A is always the ring nitrogen at position 3.
  • R may be the same as or different from R in any of the formulae given.
  • the free bases, Formula 1, and their simple salts, Formula 2 possess varying degrees of antihistaminic and brochiodilatory activity.
  • the dimeth iodide of Example I had a very favorable therapeutic ratio, at a total dosage level of 25 mg. I. M. there was a marked lowering of blood pressure and at the same time the toxicity has been determined to be 1250 mg./kg.
  • the dihydrochlride.-'Ihe base was dissolved in anhydrous isopropanol and an excess of an alcoholic solution of HCl gas was added. On cooling and adding anhydrous ethyl ether, the dihydrochloride separated as crystalline white material with a melting point over 305 C.
  • Ionic chloride Calculated-29.40%; found29.30%.
  • the dimethiodide When the base was mixed with an excess of methyl iodide in anhydrous methanol and allowed to stand, the crystalline material crystallizing or precipitated out on adding anhydrous ether was generally a mixture of the monoand di-methiodides. In order to obtain the dimethiodide free of monomethiodide, it was necessary to reflux the base with an excess of methyl iodide in anhydrous methanol for 2-4 hours. The material that crystallized on cooling or on the addition of ether to the cooled reaction mixture melted at 215-219" C. On recrystallization from ethanol it melted at 219-221" C.
  • the monomethiodide (This was obtained free from the dimethiodide by mixing molar equivalents of the free base and methyl iodide in methanol and letting the mixture stand a day at room temperature and adding ether to the cooled mixture. It had a melting point of 203-205 C. On recrystallization from isopropanol it crystallized in rectangular plates of melting point 204-206.
  • the dimethiodide can be obtained directly by reacting the base with an excess of methyl iodide in acetone and allowing the mixture to stand 1 day. On refrigeration the dimethiodide separated in crystalline form, M. P. 230-233 C. decomposition. Recrystallization from absolute ethanol sharpened the M. P. to 23023l C. decomposition. Decomposition may set in lower than the melting point if the material is heated very slowly.
  • Ionic chloride Calculated-27.78%; found-27.53%.
  • the dimethi0dide The dimethiodide formed readily with excess methyl iodide and the base in acetone at room temperature on standing 1 day. M. P. 235-238 C. Recrystallization from isopropanol-ether gave M. P. 242-243" C.
  • Ionic chloride Calculated-23.85%; found-24.00%.
  • the dimethi0dide (This was formed analogous to Example III, M. P. 223230 C. decomposition. Recrystallization from ethanol, M. P. 230-2315 C., decomposition.
  • a dimethonium 1.
  • n is a number from 1 to 6
  • R is selected from the group consisting of two alkyl groups each alkyl group having I to 6 carbon atoms and radicals which form, together with the nitrogen atom to which they are attached, heterocyclic groups consisting of morpholino, piperidino and pyrrolidino and (2) acid addition salts and mono and di-quaternary salts of 1).

Description

United States Patent DERIVATIVES OF S-AZABICYCLOHEPTANE Charles H. Grogan, Falls Church, Va., and Leonard M. Rice, Baltimore, Md., assignors to The Geschickter Fund for Medical Research, Inc., Washington, D. C., a corporation of New York No Drawing. Application October 10, 1955, Serial No. 539,652
11 Claims. (Cl. 260-2475) This invention relates to organic chemo-therapeutic agents and methods of their preparation, and more particularly relates to compounds of value in the treatment of cardio-vascular and other diseases. More specifically the invention relates to azabicycloheptane (3:2:0) bases, and the simple and monoand bis-quaternary salts thereof.
It is a basic objective of the present invention to provide novel organic compounds and methods for their preparation.
It is another object of the invention to provide novel, physiologically active compounds having chemotherapeutic or medicinal properties, particularly hypotensive ac tivity.
It is a further object of the invention to provide novel compounds comprising N-dialkylaminoalkyl-3-azabicycloheptane (3:2:0) bases and the simple, monoand hisquaternary salts thereof, and methods of synthesizing these compounds.
These and other objects and the manner in which they are accomplished will become apparent to those conversant with the art from the following description of the general class of compounds and certain specific examples of particular members as well as general and specific methods for their synthesis.
Generally stated, the novel compounds discovered are obtained by forming the N-dialkylaminoalkyl imides from the anhydride of cis-l,2-cyclobutane dicarboxylic acid, the reduction of these imides by suitable means to obtain N- dialkylaminoalkyl-3-azabicycloheptane bases which may be converted by appropriate means into the simple, monoand bis-quaternary salts.
nocc J H H H Formula 1 Formula 1 shows the general structural formula of compounds obtained by the methods hereafter more par.- ticularly described. This formula depicts the free bases, and for convenience in representation the azabicycloheptane nucleus (enclosed in parenthesis, Formula 1) will be designated by the letter A hereafter.
The simple salts of the bases illustrated by Formula I are shown by Formula 2 while the monoand bis-quater- Patented Aug. 6, 1957 ice nary salts of these bases are shown by Formulae 3(a) and 3(b) respectively.
Formula 2 R! (0Hz) H 1 i wnsrif X \R X- X \R Formula 3(a) Formula 3(1)) In these formulae A represents the azabicycloheptane nucleus and n a number from I to 6. R represents two alkyl groups with from 1 to 6 carbon atoms. R represents an alkyl group with from 1 to 6 carbon atoms, an alkylene group containing 3 carbon atoms, or the structure (N=R)' may represent a heterocyclic ring namely, morpholine, piperidine, pyrrolidine, piperazine or N- methyl piperazine. X- represents an anion namely, chloride, iodide, bromide, acetate or sulfate. The site of both simple and quaternary salt formation on the nucleus A is always the ring nitrogen at position 3. In the quaternary salts R may be the same as or different from R in any of the formulae given.
The free bases, Formula 1, and their simple salts, Formula 2, possess varying degrees of antihistaminic and brochiodilatory activity. The quaternary salts of these bases, Formula 3(a), 3(b), and in particular the hisquaternary salts, Formula 3(b), possess a marked hypotensive activity in mammals. For example the dimeth iodide of Example I had a very favorable therapeutic ratio, at a total dosage level of 25 mg. I. M. there was a marked lowering of blood pressure and at the same time the toxicity has been determined to be 1250 mg./kg.
The following examples of specific compounds and methods will illustrate the manner in which the general synthesizing procedure may be applied to obtain particular members of the class of compounds discovered. It
4 will be understood, however, that the following examples are merely illustrative and are not, nor are they intended to be, exhaustive of all the compounds embraced by the present invention.
EXAMPLE I N-dimethylaminoethyl-3-azabicycl0heptane (3:2:0)
simple salts and quaternary salts The free base.24.5 grams of the dimethylaminoethyl imide of 1,2-cis-cyclobutane dicarboxylic anhydride, dissolved in 200 ml. of anhydrous ether was added to a rapidly stirred solution of 15 g. of lithium aluminum hydride (LiAlH4) in 600 ml. of anhydrous ethyl ether. Addition was made so as to just maintain reflux. The mixture was stirred for 2 hours after all the imide solution had been added, allowed to stand overnight and then decomposed by the dropwise addition of water so that reflux was just maintained. When the evolution of hydrogen had ceased, a slight excess of water was added, the mixture stirred 1-3 hours, inorganic material filtered off and the residue washed several times with ether. The ethereal filtrate was dried over anhydrous sodium sulfate, the ether stripped off and the residue vacuum distilled tg yield 17.7 grams of colorless liquid with an amine-like odor, B. P. 38-44" C./0.3 mm.: n =1.4766.
The dihydrochlride.-'Ihe base was dissolved in anhydrous isopropanol and an excess of an alcoholic solution of HCl gas was added. On cooling and adding anhydrous ethyl ether, the dihydrochloride separated as crystalline white material with a melting point over 305 C.
Ionic chloride: Calculated-29.40%; found29.30%.
The dimethiodide.-When the base was mixed with an excess of methyl iodide in anhydrous methanol and allowed to stand, the crystalline material crystallizing or precipitated out on adding anhydrous ether was generally a mixture of the monoand di-methiodides. In order to obtain the dimethiodide free of monomethiodide, it was necessary to reflux the base with an excess of methyl iodide in anhydrous methanol for 2-4 hours. The material that crystallized on cooling or on the addition of ether to the cooled reaction mixture melted at 215-219" C. On recrystallization from ethanol it melted at 219-221" C.
Ionic iodide: Calculated-56. 14%; found-55.94%
The monomethiodide.-This was obtained free from the dimethiodide by mixing molar equivalents of the free base and methyl iodide in methanol and letting the mixture stand a day at room temperature and adding ether to the cooled mixture. It had a melting point of 203-205 C. On recrystallization from isopropanol it crystallized in rectangular plates of melting point 204-206.
Ionic iodide: Calculated-40.91% found-41. 16%
EXAMPLE II N-diethylaminoethyl-3-azabicycl0heptane (3:2:0) simple and quaternary salts Carbon Hydrogen Nitrogen Calculated. Percent 73. 41 12. 32 14. 27 Found, Percent 73. 23 i2. 19 14. 46
The dihydr0chI0ride.-Addition of an excess of a saturated solution of HCl in ethanol to the base dissolved in isopropanol, cooling and addition of. ether produced the white crystalline dihydrochloride, M. P. 2142l6 C. Recrystallization from isopropanol gave M. P. 215-216" C.
Ionic chloride: Calculated-26.34%; found-26.10%.
The dimethiodide.The dimethiodide can be obtained directly by reacting the base with an excess of methyl iodide in acetone and allowing the mixture to stand 1 day. On refrigeration the dimethiodide separated in crystalline form, M. P. 230-233 C. decomposition. Recrystallization from absolute ethanol sharpened the M. P. to 23023l C. decomposition. Decomposition may set in lower than the melting point if the material is heated very slowly.
Ionic iodide: Calculated-52.86%; found-52.79%.
EXAMPLE III N-dimethyIamin0pr0pyl-3-azabicycloheptane (3:2:0) simple and quaternary salts The free base.Reduction of 28 grams of the appropriate imide with 15 g. of lithium aluminum hydride 4 (LiAlI-Is) as detailed under Example I yielded 22 grams of the title base, B. P. 53-55 C./0.3 mm., n =1.4702.
Carbon Hydrogen Nitrogen Calculated, Percent 72. 47 12. 16 15. 37 Found, Percent 72. 63 12. 27 15. 6B
The dihya'rochI0ride.-Addition of excess alcoholic- HCl to the base in isopropanol and precipitation with ether yielded the salt with M. P. 265-268 C. Recrystallization from isopropanol-ether gave M. P. 265C.
Ionic chloride: Calculated-27.78%; found-27.53%.
The dimethi0dide.The dimethiodide formed readily with excess methyl iodide and the base in acetone at room temperature on standing 1 day. M. P. 235-238 C. Recrystallization from isopropanol-ether gave M. P. 242-243" C.
Ionic iodide: Calculated-54.4S%; found-54.48%.
EXAMPLE IV N-diethylaminopropyl-3-azabicycl0heptane (3:2:0) salts and quaternary salts The free base.-Reducti0n of the corresponding imide The dihydrochloride.-This was formed analogous to Example Ill, M. P. 19l-192 C., with no change on recrystallization from isopropanol-ether.
Ionic chloride: Calculated25.03%; found-25.20%.
The dimcthi0dide.-This was also formed analogous to Example III, M. P. -187 C. Recrystallization from isopropanol-ether, M. P. l89-l90 C.
Ionic iodide: Calculated-51.36%; found-51.25%.
EXAMPLE V N-morpholinoethyl-3azabicycloheptane (3:2:0) salts and quaternary salts The free base.-l5 grams of the imide reduced with 6 grams of lithium aluminum hydride (LiAlH4) as detailed under Example I, yielded 11 grams of the base, B. P.
The dihydr0chl0ride.This was formed analogous to Example III, M. P. 271-273 C., with no change on recrystalliztaion.
Ionic chloride: Calculated-23.85%; found-24.00%.
The dimethi0dide.-This was formed analogous to Example III, M. P. 223230 C. decomposition. Recrystallization from ethanol, M. P. 230-2315 C., decomposition.
Ionic iodide: Calculated-49.94%; found-50.06%.
From the foregoing description of a novel class of compounds, and the detailed preparation and characterization of exemplary members of the class, it will be understood that, on the basis of the discovery and knowledge disclosed herein, other specific compounds can be made and variations in the methods of synthesis resorted to. The appended table contains additional examples of bases prepared by the procedures detailed herein. Therefore, the specific compounds and methods disclosed herein are to be considered in all respects as illustrative and not restrictive, the scope of the discovery being indicated by the appended claims rather than the foregoing descriptive detailed examples, and all specific compounds and variations and methods which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
N-DIETHYLAMINOETHYL-3-AZABIOYOLOEEPTANE (322:0)
Analysis, Percent 13. P., N substituent 0. mm Carbon Hydrogen Nitrogen Calcd Found Calc'd Found Cale'd Found diethylamlnobutyL 63-68 0. 3 74. 94 d1ethy1aminoamyl. 77-83 0. 3 75. 56 diethylaminohexyl- Q4-99 0. 3 76. 12 dibutylaminoethyl- 94-99 0. 1 76. 12 dlhex lamlnoethyl--. 118122 0.08 77.85 morp olinoethyl 72-78 0,3 68.53 plparldinoethyL- 80-84 0. 2 74. 04
We claim: 5. As a novel composition of matter, a dimethonium 1. As a novel composition of matter, a compound selected from the group consisting of (1) compounds having the formula H1CC--C N(OH|)--N==R H:CCC/
H H: where, in said formula, n is a number from 1 to 6, R is selected from the group consisting of two alkyl groups each alkyl group having I to 6 carbon atoms and radicals which form, together with the nitrogen atom to which they are attached, heterocyclic groups consisting of morpholino, piperidino and pyrrolidino and (2) acid addition salts and mono and di-quaternary salts of 1).
2. As a novel composition of matter, a dimethonium salt of N dimethylaminoethyl 3 azabicycloheptane (3:210).
3. As a novel composition of matter, a dimethonium salt of N diethylaminopropyl 3 azabicycloheptane (3:2:0).
6. As a novel composition of matter, a dimethonium salt of N morpholinopropyl 3 azabicycloheptane (3:2:0).
7. As a novel composition of matter, N-dimethylaminoethyl-3 -azabicycloheptane (3 2: 0)
8. As a novel composition of matter, the dimethonium chloride of N-dimethylaminoethyl 3 azabicycloheptane (3:2:0).
9. As a novel composition of matter, N-dimethylarninopropyl-3 -azabicycloheptane (3 2:0)
10. As a novel composition of matter, the dimethonium chloride of N-dimethylaminopropyl-3-azabicycloheptane (3:2:0).
11. As a novel composition of matter, the dimethonium chloride of N-diethylaminoethyl 3 azabicycloheptane (3:2:0).
No references cited.

Claims (1)

1. AS A NOVEL COMPOSITION OF MATTER, A COMPOUND SELECTED FROM THE GROUP CONSISTING OF (1) COMPOUNDS HAVING THE FORMULA
US539652A 1955-10-10 1955-10-10 Derivatives of 3-azabicycloheptane Expired - Lifetime US2802003A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US539652A US2802003A (en) 1955-10-10 1955-10-10 Derivatives of 3-azabicycloheptane

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH813428X 1955-10-10
US539652A US2802003A (en) 1955-10-10 1955-10-10 Derivatives of 3-azabicycloheptane

Publications (1)

Publication Number Publication Date
US2802003A true US2802003A (en) 1957-08-06

Family

ID=25738542

Family Applications (1)

Application Number Title Priority Date Filing Date
US539652A Expired - Lifetime US2802003A (en) 1955-10-10 1955-10-10 Derivatives of 3-azabicycloheptane

Country Status (1)

Country Link
US (1) US2802003A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2962496A (en) * 1957-01-28 1960-11-29 Geschickter Fund Med Res Nu-substituted-3-azabicyclooctanes [3: 3: 0] and salts thereof
US3092630A (en) * 1958-12-19 1963-06-04 Gen Aniline & Film Corp Preparation of nu-substituted-3-morpholones
US6871578B1 (en) * 2000-08-24 2005-03-29 Mitsubishi Denki Kaibushiki Kaisha High-pressure fuel supply apparatus
US20050159474A1 (en) * 2002-04-03 2005-07-21 Astrazeneca Ab Chemical compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2962496A (en) * 1957-01-28 1960-11-29 Geschickter Fund Med Res Nu-substituted-3-azabicyclooctanes [3: 3: 0] and salts thereof
US3092630A (en) * 1958-12-19 1963-06-04 Gen Aniline & Film Corp Preparation of nu-substituted-3-morpholones
US6871578B1 (en) * 2000-08-24 2005-03-29 Mitsubishi Denki Kaibushiki Kaisha High-pressure fuel supply apparatus
US20050159474A1 (en) * 2002-04-03 2005-07-21 Astrazeneca Ab Chemical compounds
US7125906B2 (en) 2002-04-03 2006-10-24 Astrazeneca Ab Indole derivatives having anti-angiogenetic activity

Similar Documents

Publication Publication Date Title
US2971001A (en) Quaternary salts of triphenylethanols, -ethylenes, and -ethanes
US4234584A (en) Substituted phenylpiperazine derivatives
US4436908A (en) Heterosulfonamides
US4216231A (en) 9,10-Dihydro-9,10-methanoanthracene N-oxide derivatives
US2786834A (en) Bicycloazaoctane derivatives
US2802003A (en) Derivatives of 3-azabicycloheptane
US3865828A (en) Pyridine derivatives having antidepressant activity
US2932645A (en) Nu-(dialkylaminomethyl) benzilic amides
US2784199A (en) Endoxy isoindoline derivatives and salts thereof
US3198798A (en) Phthalimido- and isoindolinyl-alkylpiperazines and their preparation
US3891640A (en) Apovincaminic acid amines and acid addition salts thereof
NO162154B (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF URE ADDITIVES.
US2962496A (en) Nu-substituted-3-azabicyclooctanes [3: 3: 0] and salts thereof
SE462849B (en) HYDANTOIN DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US3332958A (en) Bis-(amino alkoxy phenyl)sulfides, sulfoxides and sulfones
FI69841B (en) FOERFARANDE FOER FRAMSTAELLNING AV THERAPEUTISKT ANVAENDBARA 1-PHENOXY- ELLER FENYLTIO- ELLER FENYLALKYL) -4-BENZIMIDOYLPI PEAZINER
US2669564A (en) Tertiary-aminoalkyl 4-amino-2-alkoxy-thiolbenzoates and their preparation
US2904548A (en) N-substituted-3-azabicyclo [3:3:0] octane-2, 4-diones and salts thereof
US2742472A (en) Spasmolytic pipergzjnes
US3951970A (en) Resorcinol amine derivatives
US2566376A (en) Beta-tertiary aminoethanol ethers of diaryl pyridyl carbinols
US3314970A (en) Pykrolidino ketones
US2973368A (en) 3-azabicyclo [3:2:0] heptane and derivatives thereof
US3121724A (en) Aminoalkyl ethers of 6-halobenzyl-5-indanol and 7-halobenzyl-4-indanol
US2928834A (en) 2-n-methylpiperazine-1-phenylethyl benzoates